Valsartan-induced hepatotoxicity in a HBs-Ag-positive patient [6]

American Journal of Gastroenterology

Volumn 98, Issue 2, 2003, Pages 507-

  Kiykim, Ahmet ^a   Altintas, Engin ^a   Sezgin, Orhan ^a   Sezer, Kerem ^a   Tiftik, Naci ^a   Akbay, Esen ^a   Seyrek, Ertugrul ^a   Konca, Kamuran ^a  

^a MERSIN UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; HEPATITIS B SURFACE ANTIGEN; LIVER ENZYME; VALSARTAN;

ABDOMINAL PAIN; ADULT; ANGIONEUROTIC EDEMA; ANTIHYPERTENSIVE THERAPY; CASE REPORT; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; FATIGUE; FEMALE; HEADACHE; HUMAN; HYPERTENSION; JAUNDICE; LETTER; LIVER FUNCTION TEST; LIVER TOXICITY; MUSCLE WEAKNESS; NAUSEA; PRIORITY JOURNAL; PRURITUS; RASH; TOXIC HEPATITIS; VERTIGO;

EID: 0037280311     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2003.07248.x     Document Type: Letter

References (4)

1. Rene JM. Acute hepatitis induced by valsartan. Med Clin (Barc) 2001;117:637-8.
2. Markham A, Goa KL. Valsartan. A review of its pharmacology and therapeutic use in essential hypertension. Drugs 1997;54: 299-311.
3. Frye CB, Pettigrew TJ. Angioedema and photosensitive rash induced by valsartan. Pharmacotherapy 1998;18:866-8.
4. Tabak F, Mert A, Ozaras R, et al. Losartan-induced hepatic injury. J Clin Gastroenterol 2002;34:585-6.